| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
52,373,000 |
| Market
Cap: |
2.53(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$30.85 - $52.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 474 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Vericel is a biopharmaceutical company providing cell therapies for the sports medicine and severe burn care markets. Co.'s products include: MACI®, which is an autologous cellularized scaffold product indicated for the repair of symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults; and Epicel®, which is a permanent skin replacement for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area. Co. also holds a license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
144,016 |
298,272 |
308,234 |
348,833 |
| Total Sell Value |
$6,682,454 |
$12,749,220 |
$13,114,420 |
$14,216,679 |
| Total People Sold |
6 |
7 |
7 |
7 |
| Total Sell Transactions |
12 |
29 |
34 |
37 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2019-06-10 |
4 |
AS |
$15.53 |
$273,373 |
D/D |
(17,500) |
122,672 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2019-06-10 |
4 |
OE |
$2.75 |
$50,488 |
D/D |
17,500 |
140,172 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2019-05-13 |
4 |
AS |
$17.02 |
$297,859 |
D/D |
(17,500) |
122,672 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2019-05-13 |
4 |
OE |
$2.75 |
$48,125 |
D/D |
17,500 |
140,172 |
|
- |
|
| Gilman Steven C |
|
– • – |
2019-05-01 |
4 |
AS |
$16.81 |
$126,095 |
D/D |
(7,500) |
0 |
|
- |
|
| Gilman Steven C |
|
– • – |
2019-05-01 |
4 |
OE |
$2.76 |
$20,700 |
D/D |
7,500 |
7,500 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2019-04-08 |
4 |
AS |
$17.37 |
$275,592 |
D/D |
(15,625) |
122,672 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2019-04-08 |
4 |
OE |
$2.65 |
$50,375 |
D/D |
15,625 |
124,547 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2019-03-11 |
4 |
AS |
$20.02 |
$200,235 |
D/D |
(10,000) |
122,249 |
|
- |
|
| Gilman Steven C |
|
– • – |
2019-02-28 |
4 |
AS |
$18.02 |
$135,129 |
D/D |
(7,500) |
0 |
|
- |
|
| Gilman Steven C |
|
– • – |
2019-02-28 |
4 |
OE |
$2.76 |
$20,700 |
D/D |
7,500 |
7,500 |
|
- |
|
| Colangelo Dominick |
President and CEO |
• • – |
2019-02-15 |
4 |
OE |
$1.95 |
$99,999 |
D/D |
36,192 |
111,355 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2019-02-11 |
4 |
AS |
$17.09 |
$170,880 |
D/D |
(10,000) |
132,249 |
|
- |
|
| Zerbe Robert L Md |
|
– • – |
2019-01-22 |
4 |
OE |
$2.63 |
$46,025 |
D/D |
17,500 |
17,545 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2019-01-14 |
4 |
AS |
$17.17 |
$149,627 |
D/D |
(8,711) |
142,249 |
|
- |
|
| Wotton Paul K |
|
– • – |
2019-01-02 |
4 |
AS |
$16.83 |
$378,693 |
D/D |
(22,500) |
0 |
|
- |
|
| Wotton Paul K |
|
– • – |
2019-01-02 |
4 |
OE |
$2.63 |
$59,825 |
D/D |
22,500 |
17,500 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2018-12-10 |
4 |
AS |
$16.81 |
$262,656 |
D/D |
(15,625) |
150,960 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2018-12-10 |
4 |
OE |
$1.95 |
$34,406 |
D/D |
15,625 |
166,585 |
|
- |
|
| Gilman Steven C |
|
– • – |
2018-12-03 |
4 |
AS |
$17.75 |
$150,908 |
D/D |
(8,500) |
0 |
|
- |
|
| Gilman Steven C |
|
– • – |
2018-12-03 |
4 |
OE |
$2.63 |
$22,355 |
D/D |
8,500 |
8,500 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2018-11-12 |
4 |
AS |
$15.90 |
$238,500 |
D/D |
(15,000) |
150,960 |
|
- |
|
| Michel Gerard J |
CFO and VP, Corp. Development |
• – – |
2018-11-12 |
4 |
OE |
$1.95 |
$29,250 |
D/D |
15,000 |
165,960 |
|
- |
|
| Colangelo Dominick |
President and CEO |
• • – |
2018-11-06 |
4 |
AS |
$15.39 |
$769,500 |
D/D |
(50,000) |
75,163 |
|
- |
|
| Colangelo Dominick |
President and CEO |
• • – |
2018-11-06 |
4 |
OE |
$2.75 |
$137,500 |
D/D |
50,000 |
125,163 |
|
- |
|
303 Records found
|
|
Page 11 of 13 |
|
|
0.24 (0.5%) 
